Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1968 3
1970 1
1972 1
1974 1
1975 1
1976 1
1977 1
1978 3
1980 3
1982 1
1984 2
1985 1
1988 1
1989 4
1992 2
1993 4
1994 1
1995 3
1996 1
1997 2
1998 4
1999 2
2001 1
2002 1
2004 1
2005 2
2006 3
2007 3
2008 2
2009 3
2010 5
2011 2
2012 1
2013 4
2014 3
2015 1
2016 6
2017 11
2018 8
2019 4
2020 6
2021 5
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A, Schwartz S, Vinks AA, Heldrup J. Ramsey LB, et al. Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Oncologist. 2018. PMID: 29079637 Free PMC article.
Acute kidney injury due to high-dose methotrexate (HDMTX) is a serious, life-threatening toxicity that can occur in pediatric and adult patients. Glucarpidase is a treatment approved by the Food and Drug Administration for high methotrexate concentrations in the context of …
Acute kidney injury due to high-dose methotrexate (HDMTX) is a serious, life-threatening toxicity that can occur in pediatric and adu …
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. Trpkov K, et al. Mod Pathol. 2021 Jul;34(7):1392-1424. doi: 10.1038/s41379-021-00779-w. Epub 2021 Mar 4. Mod Pathol. 2021. PMID: 33664427 Free article.
New papillary RCC variants/patterns include biphasic, solid, Warthin-like, and papillary renal neoplasm with reverse polarity. For tumors with 'borderline' features between oncocytoma and chromophobe RCC, a term "oncocytic renal neoplasm of low malignant pote …
New papillary RCC variants/patterns include biphasic, solid, Warthin-like, and papillary renal neoplasm with reverse polarity. For tu …
Management of bilateral Wilms tumours.
Millar AJ, Cox S, Davidson A. Millar AJ, et al. Pediatr Surg Int. 2017 Apr;33(4):461-469. doi: 10.1007/s00383-016-4047-2. Epub 2017 Jan 4. Pediatr Surg Int. 2017. PMID: 28054101 Review.
It is an embryonal tumour derived from the metanephros. It is the commonest childhood renal tumour and the third commonest paediatric malignancy. ...The major clinical challenge in BWTs is preservation of functioning renal tissue using nephron sparing surgical techniques, …
It is an embryonal tumour derived from the metanephros. It is the commonest childhood renal tumour and the third commonest paediatric …
Management of bilateral Wilms tumours.
Millar AJW, Cox S, Davidson A. Millar AJW, et al. Pediatr Surg Int. 2017 Jul;33(7):737-745. doi: 10.1007/s00383-017-4091-6. Epub 2017 May 17. Pediatr Surg Int. 2017. PMID: 28516188 Review.
It is an embryonal tumour derived from the metanephros. It is the commonest childhood renal tumour and the third commonest paediatric malignancy. ...The major clinical challenge in BWTs is preservation of functioning renal tissue using nephron-sparing surgical techniques, …
It is an embryonal tumour derived from the metanephros. It is the commonest childhood renal tumour and the third commonest paediatric …
Guide for paediatric radiotherapy procedures.
Laprie A, Bernier V, Padovani L, Martin V, Chargari C, Supiot S, Claude L. Laprie A, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):356-367. doi: 10.1016/j.canrad.2021.11.018. Epub 2021 Dec 27. Cancer Radiother. 2022. PMID: 34969622
The treatment guidelines follow the recommendations of the French society for childhood cancers (SFCE) or the French and European prospective protocols. ...The irradiation methods include all the techniques currently available: 3D conformational irradiation, intensity modu …
The treatment guidelines follow the recommendations of the French society for childhood cancers (SFCE) or the French and European pro …
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC, Raphaël MF, Caron HN, Kremer LC. van Dalen EC, et al. Cochrane Database Syst Rev. 2014 Sep 4;(9):CD006647. doi: 10.1002/14651858.CD006647.pub4. Cochrane Database Syst Rev. 2014. PMID: 25188452 Review.
A well-informed decision on the use of anthracyclines in the treatment of childhood cancers should be based on evidence regarding both antitumour efficacy and cardiotoxicity. ...SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing treatment of any type of c …
A well-informed decision on the use of anthracyclines in the treatment of childhood cancers should be based on evidence regarding bot …
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.
van Dalen EC, Raphaël MF, Caron HN, Kremer LC. van Dalen EC, et al. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006647. doi: 10.1002/14651858.CD006647.pub3. Cochrane Database Syst Rev. 2011. PMID: 21249679 Updated. Review.
A well-informed decision on the use of anthracyclines in the treatment of childhood cancers should be based on evidence regarding both antitumour efficacy and cardiotoxicity. ...SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing treatment of any type of c …
A well-informed decision on the use of anthracyclines in the treatment of childhood cancers should be based on evidence regarding bot …
Management of Wilms Tumor: ICMR Consensus Document.
Prasad M, Vora T, Agarwala S, Laskar S, Arora B, Bansal D, Kapoor G, Chinnaswamy G, Radhakrishnan V, Kaur T, Rath GK, Bakhshi S. Prasad M, et al. Indian J Pediatr. 2017 Jun;84(6):437-445. doi: 10.1007/s12098-017-2305-5. Epub 2017 Apr 3. Indian J Pediatr. 2017. PMID: 28367612 Review.
Wilms tumor (WT) is the most common renal tumor of childhood. Although multidisciplinary care including surgery, chemotherapy and radiotherapy have greatly improved the survival rates in WT, there is a scope for further improvement in India and other resource-poor s …
Wilms tumor (WT) is the most common renal tumor of childhood. Although multidisciplinary care including surgery, chemotherapy …
Pharmacotherapeutic Management of Wilms Tumor: An Update.
Oostveen RM, Pritchard-Jones K. Oostveen RM, et al. Paediatr Drugs. 2019 Feb;21(1):1-13. doi: 10.1007/s40272-018-0323-z. Paediatr Drugs. 2019. PMID: 30604241 Review.
For recurrent WT, a unified approach based on the use of agents that were not used for primary therapy is being introduced. Irinotecan is being explored as a new strategy in both metastatic and relapsed WT. ...Molecular profiling studies are in progress that should ultimat …
For recurrent WT, a unified approach based on the use of agents that were not used for primary therapy is being introduced. Irinoteca …
Dimethylarginines in Children after Anti-Neoplastic Treatment.
Jezierska M, Owczarzak A, Stefanowicz J. Jezierska M, et al. Medicina (Kaunas). 2022 Jan 11;58(1):108. doi: 10.3390/medicina58010108. Medicina (Kaunas). 2022. PMID: 35056416 Free PMC article.
Background and Objectives: According to a recent Cochrane systematic review, renal impairment can develop in 0-84% of childhood cancer survivors in the future. The renal function impairment in this patient group can be related to nephrectomy, nephrotoxic agents therapy …
Background and Objectives: According to a recent Cochrane systematic review, renal impairment can develop in 0-84% of childhood cance …
118 results